Results 291 to 300 of about 9,218,862 (344)

RBC Membrane‐Camouflaged Nanosystem‐Mediated Synergistic Drug Combination for Enhanced Anti‐Tumor Therapy

Advanced Healthcare Materials, EarlyView.
An RBC membrane camouflaged, cell‐penetrating peptides R8‐based drug delivery system is constructed to achieve a synergistic combination of natural compounds triptolide (TP) and celastrol (Cel), inducing tumor cell apoptosis, reducing tumor metastasis invasion and triggering autophagy disorder in breast cancer and liver cancer.
Qian Cheng, Xuemei Zhong, Lu Deng, Xinling He, Miaoxizi Luo, Ruibing Wang, Jinming Zhang   +6 more
wiley   +1 more source

Frequency and predictors of depression and anxiety in chronic illnesses: A multi disease study across non-communicable and communicable diseases. [PDF]

PLoS One
Abbas U, Hussain N, Tanveer M, Laghari RN, Ahmed I, Rajper AB.   +5 more
europepmc   +1 more source

Direct Surface Modification of the Epidermis Using Mussel‐Inspired Polydopamine with Multiple Anti‐Biofouling Functions

Advanced Healthcare Materials, EarlyView.
Surface modification using mussel‐derived polydopamine (PDA) is a versatile and robust biocompatible strategy that enables direct application to various epidermal surfaces, regardless of their morphological complexity or surface characteristics. The PDA‐coated epidermis exhibits multiple anti‐biofouling functionalities, including antibacterial and anti‐
Su Eon Lee, Hanna Lee, Jang Hwan Kim, Sungwook Park, Young Taek Oh, Hayoung Choi, Jeong‐Min Kim, Hye‐Jun Jo, Jun Hyun Park, Ho Jun Jin, Kwan Hyi Lee, Seung Ho Han, Hojun Kim, Jun Kyun Oh, Bong Hoon Kim   +14 more
wiley   +1 more source

World health Organization's guidance for tracking non-communicable diseases towards sustainable development goals 3.4: an initiative for facility-based monitoring. [PDF]

EClinicalMedicine
Quiambao A, Malekpour MR, Golestani A, Heidari-Foroozan M, Ghamari SH, Abbasi-Kangevari M, Anderson BO, Barango P, Fidarova E, Hemmingsen B, Ilbawi A, Khan T, Sequeria RO, Roglic G, Rylance S, Roitberg F, Riley L, Slama S, Bhatti L, Cowan M, Rarau P, Savin S, Farzadfar F, Agboyibor KM, Aggarwal AN, Akala O, Angkurawaranon C, Chu HA, Anjana RM, Antini C, Aziz Z, Barkley S, Basit A, Basu P, Majano SB, Bennoor K, Brettler JW, Cabioglu N, Caixeta R, Campbell N, Chavez C, Choudhury SR, Corbex MA, Cruz A, Daceney N, Dalal S, Danaei G, Dangou JM, De Groote W, Diallo CB, Dille I, Domingo RE, Dorji G, Duncan BB, Egere U, El Berri H, El Sony A, Eltigani M, Farrington J, Fouad H, Friedrich P, Fuentes-Alabi S, Gamarra A, Gregg E, Gupta R, Gupta S, Jia W, Jiagge E, Jousilahti P, Kesavan R, Kumar S, Laatikainen T, Larijani B, Losada ML, Le Thi TL, Levitt N, Luciani S, Maza M, Mikkelsen B, Mohammad Y, Moran A, Motlagh A, Mulupi S, Murillo RH, Mutebi M, Nantanda R, Nyirenda M, O'Connor P, Ojji D, Omoro GE, Ondarsuhu D, Ordunez P, Sidi Mohamed MO, Owolabi M, Rahimi K, Rakovac I, Raposo JF, Rosende A, Rowley J, Sankaranarayanan R, Smelov V, Tiko J, Tonelli M, Tsoyi E, Tuttle T, Varghese C, Vásquez L, Viswanathan K, Xu H, Yip CH.   +109 more
europepmc   +1 more source

Progress of Immune‐Inducible Biomaterials for Post‐Ablation Cancers

Advanced Healthcare Materials, EarlyView.
The presence of residual tumors after ablative therapies poses a significant challenge, generally resulting in recurrence and metastases. This review offers a concise overview of immune‐inducible biomaterials from the perspective of the cancer‐immunity cycle, and how they enhance antitumor immunity through diverse mechanisms following ablative ...
Shuangshuang Zhao, Zheng Zhang, Xincai Wu, Yanwei Chen, Wenjun Li, Jiayan Bao, Xin Zhang, Baoding Chen   +7 more
wiley   +1 more source

Editorial: Reviews in experimental pharmacology and drug discovery 2023: pharmacological management of non-communicable diseases. [PDF]

Front Pharmacol
Sharif A, Flores-Morales V, Aly HF.
europepmc   +1 more source

Peptide Display Directed Assembly of Biopolymer Core–Silica Shell Particles

Advanced Healthcare Materials, EarlyView.
Bacterial cells are engineered to produce biopolyester particles displaying peptides mediating growth of silica. Peptide‐coated biopolyester particles are treated with silica precursors and silica shell formation is studied. Transmission electron microscopy shows silica‐coated BPs which are formed after the silicification treatment. Characterization of
Deeptee Chandrashekhar Pande, Frank Sainsbury, Bernd H. A. Rehm   +2 more
wiley   +1 more source

Impact of migrants on communicable diseases in Thailand. [PDF]

BMC Public Health
Lerskullawat A, Puttitanun T.
europepmc   +1 more source

THE CONTROL OF COMMUNICABLE DISEASES

American Journal of Public Health, 1918
openaire   +3 more sources